Expression of Bcl-2 is a favorable prognostic biomarker in lung squamous cell carcinoma

Lung squamous cell carcinoma (LUSC) is the second major type of lung cancer globally. The majority of patients with LUSC are clinically diagnosed at the advanced stages, thus it is urgent to identify suitable prognostic markers for LUSC. B-cell lymphoma 2 (Bcl-2) has been widely studied in non-small...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncol Lett
Main Authors: Feng, Changjiang, Wu, Jiaqi, Yang, Fan, Qiu, Mangtang, Hu, Shuofeng, Guo, Saisai, Wu, Jin, Ying, Xiaomin, Wang, Jun
Formato: Artigo
Idioma:Inglês
Publicado: D.A. Spandidos 2018
Assuntos:
Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5920356/
https://ncbi.nlm.nih.gov/pubmed/29725421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2018.8198
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares